Follicle stimulating hormone Manufacturers

Markets of interest

Follicle-stimulating hormones (FSH) are used for the treatment of infertility in women who cannot ovulate. There are two types of follicle-stimulating hormones currently in use: follitropin for which preparation is used recombinant DNA origin, and urofollitropin, a urinary-derived (FSH) that is extracted and purified from human urine samples. The substance is not effective in women with primary ovarian failure (when the ovaries are unable to produce an egg). This type of medication is also used in men to stimulate sperm production. Follicle-stimulating hormone is often used together with another drug called human chorionic gonadotropin (hCG). The drug is available for sale in the form of vials and capsules from manufacturers in various countries including Y. The drug is provided by a wide range of Follicle-stimulating hormone suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Follicle-stimulating hormone manufacturers and distributors are based in India.

Licensing and brand names

Urofollitropin under the trade name Bravelle was approved by the FDA in the USA in 2002. Folliotropin under the trade name Bemfola was approved by the EMA in the European Union in 2014. The medication is presently approved in many countries and is available in both generic and trade name versions. The urofollitropin medication is marketed under the trade names including the abovementioned Bravelle and, also Metrodin. One of the most popular branded versions of Follicle-stimulating hormone is manufactured and supplied by the Canadian pharmaceutical company Serono laboratories inc and Organon USA inc, located in the United States. Other manufacturing companies and distributors from Canada, Argentina, USA, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Follicle-stimulating hormone as an active ingredient.

Target supply price

The wholesale acquisition cost of medication in the USA for Follicle stimulating hormone vial, depending on the medication concentration, ranges from 117 USD to 733 USD. The retail price in the EU of this drug for the vial is around 235EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Follicle-stimulating hormone manufacturers and suppliers that you are looking for. You can also find the dossier status of Follicle-stimulating hormone and the GMP approvals of the different variants of the medication. The product description of all Follicle-stimulating hormone suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Follicle-stimulating hormone is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.